Quantification of Lipoprotein(A): Comparison of an Automated Latex-Enhanced Nephelometric Assay With an Immunoenzymometric Method

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 2, 1996, Pages 119-124

  Schmidt, Hartmut H J ^a   Gensche, JanineC ^a   Wagner, Siegfried ^a   Manns, Michael p ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; TRIACYLGLYCEROL;

ACCURACY; ARTICLE; AUTOMATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME IMMUNOASSAY; HUMAN; LIGHT SCATTERING; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NEPHELOMETRY; PARTICLE SIZE; PRIORITY JOURNAL; RISK;

HUMANS; HYPERLIPOPROTEINEMIAS; IMMUNOENZYME TECHNIQUES; LATEX; LIPOPROTEIN(A); NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS;

EID: 0030022839     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.2.119     Document Type: Article

References (51)

1. Wiklund O, Angelin B, Olofsson S-O, Erikson M, Fager G, Berglund L, et al. Apolipoprotein(a) and ischemic heart disease in familial hypercholesterolemia. Lancet 1990; 335: 1360-3.
2. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, et al. The association between Lp(a) concentrations and angiographically assessed coronary atherosclerosis-dependence on serum LDL-levels. Atherosclerosis 1986; 62: 249-257.
3. Berg K, Dahlen G, Borresen AL. Lp(a) phenotypes, other lipoprotein parameters and familial history of heart disease in middle-aged males. Clin Genet 1979; 16: 347-352.
4. Loscalzo J. A unique risk factor for atherothrombotic disease. Arteriosclerosis 1990; 10: 672-679.
5. Gushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TMA, Guyton JR, et al. Quantitation and localization of apolipoprotein(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989; 9: 593-603.
6. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132-137.
7. Brown MS, Goldstein JL. Teaching old dogmas new tricks. Nature 1987; 330: 113-114.
8. Guevara J Jr, Spurlino J, Jan AY, Yang C-Y, Tulinsky A, Venkataram Prasad BV, et al. Proposed mechanisms for binding of apo(a) kringle type 9 to apoBlOO in human lipoprotein(a). Biophys J 1993; 64: 686-700.
9. Philips ML, Lembertas AV, Schumaker VN. Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complex. Biochemistry 1993; 32: 3722-8.
10. Huby T, Doucet C, Dieplinger H, Chapman J, Thillet J. Structural domains of apolipoprotein (a) and its interaction with lipoprotein B100 in the lipoprotein(a) particle. Biochemistry 1994; 33: 3335-41.
11. Koschinsky ML, Cote GP, Gabel B, Vanderhoek YY. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B100. J Biol Chem 1993; 268: 19819-25.
12. Utermann G, Menzel HJ, Kraft HG, Duba CH, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotype. Inheritance and relation to Lp(a)-lipoprotein concentration in plasma. J Clin Invest 1987; 80: 458-465.
13. Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its-mRNA. Biochemistry 1990; 29: 640-644.
14. Morrisett JD, Gaubatz JW, Knapp RD, Guevara JG Jr. Structural properties of apo(a): a major apoprotein of human lipoprotein(a). In: Scanu A, editor. Lipoprotein (a). San Diego: Academic Press Inc 1990: 53-74.
15. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993; 2: 933-940.
16. van der Hoeck YY, Wittekoek ME, Beisiegel U, Kastelein JJ, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet 1993; 2: 361-366.
17. Edelberg J, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagulation and Fibrinolysis 1991; 2: 759-764.
18. Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein(a): properties and immunochemical measurement. Clin Chem 1990; 36: 2019-26.
19. Albers JJ, Hazzard WR. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids 1974; 9: 15-26.
20. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18: 331-338.
21. Vu-Dac N, Chekkor A, Parra H, Duthilleul P, Fruchart JC. Latex immunoassay of human serum Lp(a) lipoprotein. J Lipid Res 1985; 26: 267-269.
22. Cazzolato G, Prakasch G, Green S, Kostner GM. The determination of lipoprotein(a) by rate and endpoint nephelometry. Clin Chim Acta 1983; 135: 203-208.
23. Levine DM, Sloan BJ, Donner JE, Lorenz JD, Henzerling R. Automated measurement of Lp(a) by immunoturbidimetric analysis. Int J Clin Lab Res 1992; 22: 173-178.
24. Gillery P, Arthuis P, Cuperlier C, Circaud R. Rate nephelometric assay of serum lipoprotein(a). Clin Chem 1993; 39: 503-508.
25. Borque L, Maside C, Iglesias A. Automated turbidimetry of serum lipoprotein(a). Eur J Clin Chem Clin Biochem 1993; 31: 869-874.
26. Taddei-Peters WC, Butman BT, Jones GR, Venetta TM, Macomber PF, Ransom JH. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal antiapolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem 1993; 39: 1382-9.
27. Kottke BA, Bren ND. A particle concentration fluorescence immunoassay for Lp(a). Chem Phys Lipids 1994; 67/68:249-256.
28. Kessler A, Schumacher M, Wood WG. Immunoluminometric assays for the quantification of apolipoprotein A-I, apolipoprotein B, apolipoprotein C-II, apolipoprotein(a) and lipoprotein(a). Eur J Clin Chem Clin Biochem 1994; 32: 127-135.
29. Marcovina SM, Albers JJ, Gabel B, Koschinsky M, Gaur VP. The effect of the number of apo(a) kringle 4 domains on the immunochemical measurement of Lp(a). Clin Chem 1995; 41: 246-255.
30. Albers JJ, Marcovina SM. Standardization of Lp(a) measurements. Chem Phys Lipids 1994; 67/68:257-263.
31. Labeur C, Rosseneu M, Henderson O. International Lp(a) standardization. Chem Phys Lipids 1994; 67/68:265-270.
32. Wahlefeld AW. Triglyzeride: Bestimmung und enzymatische Verseifung. In: Bergmeyer HU, editors. Methoden der enzymatischen Analyse. 3rd ed. Weinheim: Verlag Chemie 1974; 2: 1878-82.
33. März W, Siekmeier R, Gross E, Gross W. Determination of lipoprotein(a): enzyme immunoassay and immunoradiometric assay compared. Clin Chim Acta 1993; 214: 153-163.
34. März W, Siekmeier R, Gross W, Kostner GM. Determination for lipoprotein(a): evaluation of three methods. Eur J Clin Chem Clin Biochem 1993; 31: 295-301.
35. Tiran A, Tiran B, Hojas S, Kostner GM, Wiiders-Truschnig MM. Immunoquantification of lipoprotein(a): comparison of nephelometry with electroimmunodirrusion. J Clin Lab Analysis 1993; 7: 256-262.
36. Riesen WF, Lenz A, Keller B, Engler H. Immunonephelometrische und immunoradiometrische Bestimmung von Lp(a). Labor-Medizin 1993; 9: 326-337.
37. Borque L, Rus A, del Cura J, Maside C, Escanero J. Automated latex nephelometric immunoassay for the measurement of serum lipoprotein(a), J Clin Lab Analysis 1993; 7: 105-110.
38. Fink PC, Römer M, Haeckel R. Measurement of proteins with the Behring Nephelometer: a multicentre evaluation. J Clin Chem Clin Biochem 1989; 27: 261-276.
39. Buffone GJ, Lewis SA. Advantages of small angle light scattering measurement for immunonephelometry. In: Peters H, Wright PH, editors. Plasma protein pathology. Oxford: Pergamon Press, 1979: 55-61.
40. Sternberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitation reactions. Clin Chem 1977; 23: 1456-64.
41. Passing H, Bablock W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709-720.
42. Fless GM, Snyder ML, Furbec JW Jr, Hedo MTG, Mora R. Subunit composition of Hpoprotein(a) protein. Biochemistry 1994; 33: 13492-501.
43. Sines J, Rothnagel R, van Heel M, Gaubatz JW, Morrisett JD, Chiu W. Electron cryomicroscopy and digital image processing of Jipoprotein(a). Chem Phys Lipids 1994; 67/69:81-89.
44. Hixson JE, Britten ML, Manis GS, Rainwater DL. Apolipoprotein(a) glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J Biol Chem 1989; 264: 6013-6.
45. Blanco-Vaca F, Gaubatz JW, Bren N, Kottke BA, Morrisett JD. Guevara J Jr. Identification and quantification of apolipoproteins in addition to apo(a) and apoBlOO in human lipoprotein(a). Chem Phys Lipids 1994; 67/68:35-42.
46. Bard JM, Delattre-Lestavel S, Clavey V, Pont P, Derudas B, Parra HJ, Fruchtart JC. Isolation and characterization of two subspecies of Lp(a), one containing apoE and one free of apoE. Biochim Biophys Acta 1992; 1127: 124-130.
47. Scanu AM, Pfaffinger D, Edelstein C. Postprandial Lp(a): identification of triglyceride-rich particle containing apoE. Chem Phys Lipids 1994; 67/68:193-198.
48. Labeur C, Rosseneu M. Methods for the measurement of lipoprotein(a) in the clinical laboratory. Curr Opiri Lipidol 1992; 3: 372-376.
49. Marcovina SM, Levine DM, Lippi G. Lipoprotein(a): structure, measurements, and clinical significance. In: Rifai N, Warnick R, editors. Laboratory measurement of lipids, lipoproteins, and apolipoproteins. Washington DC: American Association for Clinical Chemistry Inc 1994: 235-63.
50. Usher DC, Swanson C, Rader DJ, Kremer J, Brewer HB Jr. A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies. Chem Phys Lipids 1994; 67/68:243-248.
51. Fett TL, Kühn K, Wechsler JG, Ditschuneit H. Enzyme-linked immunosorbent assay oder Elektrophorese? Ein Methodenvergleich. Labor-Medizin 1991; 14: 455-459.